Viral genes as oncolytic agents for cancer therapy

Cell Mol Life Sci. 2015 Mar;72(6):1073-94. doi: 10.1007/s00018-014-1782-1. Epub 2014 Nov 19.

Abstract

Many viruses have the ability to modulate the apoptosis, and to accomplish it; viruses encode proteins which specifically interact with the cellular signaling pathways. While some viruses encode proteins, which inhibit the apoptosis or death of the infected cells, there are viruses whose encoded proteins can kill the infected cells by multiple mechanisms, including apoptosis. A particular class of these viruses has specific gene(s) in their genomes which, upon ectopic expression, can kill the tumor cells selectively without affecting the normal cells. These genes and their encoded products have demonstrated great potential to be developed as novel anticancer therapeutic agents which can specifically target and kill the cancer cells leaving the normal cells unharmed. In this review, we will discuss about the viral genes having specific cancer cell killing properties, what is known about their functioning, signaling pathways and their therapeutic applications as anticancer agents.

Publication types

  • Review

MeSH terms

  • Adenoviridae / genetics
  • Animals
  • Apoptosis
  • Capsid Proteins / analysis
  • Capsid Proteins / genetics
  • Chicken anemia virus / genetics
  • Genes, Viral*
  • Humans
  • Neoplasms / therapy*
  • Oncolytic Virotherapy / methods*
  • Oncolytic Viruses / genetics*
  • Parvovirus / genetics

Substances

  • Capsid Proteins
  • VP3 protein, Chicken anemia virus